Haloperidol concentrations in patients with Alzheimer's dementia

M. W. Dysken, S. B. Johnson, L. Holden, G. Vatassery, J. Nygren, M. Jelinski, M. Kuskowski, L. Schut, J. R. McCarten, David S Knopman, G. J. Maletta, S. Skare

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

To investigate the relationship between clinical response and haloperidol blood concentrations in Alzheimer's dementia (AD) patients with behavior problems, 29 AD inpatients were assigned to a fixed oral dosage of haloperidol (0.5 mg, 1.0 mg, or 2.0 mg) every 12 hours for 3 weeks. BEHAVE- AD ratings and concentrations of plasma and RBC haloperidol and reduced haloperidol were obtained on Days 8, 15, and 22. Although no significant linear or curvilinear relationships were apparent between percent of change on BEHAVE-AD and plasma or RBC haloperidol concentrations, a good response (change ≥ 30%) was observed in 55% of the patients who entered the study.

Original languageEnglish (US)
Pages (from-to)124-133
Number of pages10
JournalAmerican Journal of Geriatric Psychiatry
Volume2
Issue number2
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Haloperidol
Alzheimer Disease
Inpatients

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Dysken, M. W., Johnson, S. B., Holden, L., Vatassery, G., Nygren, J., Jelinski, M., ... Skare, S. (1994). Haloperidol concentrations in patients with Alzheimer's dementia. American Journal of Geriatric Psychiatry, 2(2), 124-133. https://doi.org/10.1097/00019442-199405000-00006

Haloperidol concentrations in patients with Alzheimer's dementia. / Dysken, M. W.; Johnson, S. B.; Holden, L.; Vatassery, G.; Nygren, J.; Jelinski, M.; Kuskowski, M.; Schut, L.; McCarten, J. R.; Knopman, David S; Maletta, G. J.; Skare, S.

In: American Journal of Geriatric Psychiatry, Vol. 2, No. 2, 1994, p. 124-133.

Research output: Contribution to journalArticle

Dysken, MW, Johnson, SB, Holden, L, Vatassery, G, Nygren, J, Jelinski, M, Kuskowski, M, Schut, L, McCarten, JR, Knopman, DS, Maletta, GJ & Skare, S 1994, 'Haloperidol concentrations in patients with Alzheimer's dementia', American Journal of Geriatric Psychiatry, vol. 2, no. 2, pp. 124-133. https://doi.org/10.1097/00019442-199405000-00006
Dysken, M. W. ; Johnson, S. B. ; Holden, L. ; Vatassery, G. ; Nygren, J. ; Jelinski, M. ; Kuskowski, M. ; Schut, L. ; McCarten, J. R. ; Knopman, David S ; Maletta, G. J. ; Skare, S. / Haloperidol concentrations in patients with Alzheimer's dementia. In: American Journal of Geriatric Psychiatry. 1994 ; Vol. 2, No. 2. pp. 124-133.
@article{3a07137d02b24d4cae50e20b6d0d658d,
title = "Haloperidol concentrations in patients with Alzheimer's dementia",
abstract = "To investigate the relationship between clinical response and haloperidol blood concentrations in Alzheimer's dementia (AD) patients with behavior problems, 29 AD inpatients were assigned to a fixed oral dosage of haloperidol (0.5 mg, 1.0 mg, or 2.0 mg) every 12 hours for 3 weeks. BEHAVE- AD ratings and concentrations of plasma and RBC haloperidol and reduced haloperidol were obtained on Days 8, 15, and 22. Although no significant linear or curvilinear relationships were apparent between percent of change on BEHAVE-AD and plasma or RBC haloperidol concentrations, a good response (change ≥ 30{\%}) was observed in 55{\%} of the patients who entered the study.",
author = "Dysken, {M. W.} and Johnson, {S. B.} and L. Holden and G. Vatassery and J. Nygren and M. Jelinski and M. Kuskowski and L. Schut and McCarten, {J. R.} and Knopman, {David S} and Maletta, {G. J.} and S. Skare",
year = "1994",
doi = "10.1097/00019442-199405000-00006",
language = "English (US)",
volume = "2",
pages = "124--133",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Haloperidol concentrations in patients with Alzheimer's dementia

AU - Dysken, M. W.

AU - Johnson, S. B.

AU - Holden, L.

AU - Vatassery, G.

AU - Nygren, J.

AU - Jelinski, M.

AU - Kuskowski, M.

AU - Schut, L.

AU - McCarten, J. R.

AU - Knopman, David S

AU - Maletta, G. J.

AU - Skare, S.

PY - 1994

Y1 - 1994

N2 - To investigate the relationship between clinical response and haloperidol blood concentrations in Alzheimer's dementia (AD) patients with behavior problems, 29 AD inpatients were assigned to a fixed oral dosage of haloperidol (0.5 mg, 1.0 mg, or 2.0 mg) every 12 hours for 3 weeks. BEHAVE- AD ratings and concentrations of plasma and RBC haloperidol and reduced haloperidol were obtained on Days 8, 15, and 22. Although no significant linear or curvilinear relationships were apparent between percent of change on BEHAVE-AD and plasma or RBC haloperidol concentrations, a good response (change ≥ 30%) was observed in 55% of the patients who entered the study.

AB - To investigate the relationship between clinical response and haloperidol blood concentrations in Alzheimer's dementia (AD) patients with behavior problems, 29 AD inpatients were assigned to a fixed oral dosage of haloperidol (0.5 mg, 1.0 mg, or 2.0 mg) every 12 hours for 3 weeks. BEHAVE- AD ratings and concentrations of plasma and RBC haloperidol and reduced haloperidol were obtained on Days 8, 15, and 22. Although no significant linear or curvilinear relationships were apparent between percent of change on BEHAVE-AD and plasma or RBC haloperidol concentrations, a good response (change ≥ 30%) was observed in 55% of the patients who entered the study.

UR - http://www.scopus.com/inward/record.url?scp=0028091617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028091617&partnerID=8YFLogxK

U2 - 10.1097/00019442-199405000-00006

DO - 10.1097/00019442-199405000-00006

M3 - Article

VL - 2

SP - 124

EP - 133

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 2

ER -